Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/CE

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/CE(x) 9.52-0.030.06-0.07-0.05

What is the latest EV/CE ratio of MANKIND PHARMA ?

The latest EV/CE ratio of MANKIND PHARMA is 9.52 based on Mar2024 Consolidated results.
Year EV/CE
Mar20249.52
Mar2023-0.03
Mar20220.06
Mar2021-0.07
Mar2020-0.05

How is EV/CE of MANKIND PHARMA Trending?

Years EV/CE % Change
Mar2024 9.52
Positive
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07
Negative
Mar2020 -0.05 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/CE ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹95,859.9 Cr -2.5% -8.3% 5.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,254.0 Cr -2.5% -4.9% 8.7% Stock Analytics
DIVIS LABORATORIES ₹172,374.0 Cr -2.7% -0.9% 42.5% Stock Analytics
CIPLA ₹119,795.0 Cr -1.5% 0.1% -4.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,698.0 Cr -2.6% 8.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,218.0 Cr -2.6% -3.7% 11.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.5%

-8.3%

5.2%

SENSEX

-0.4%

0.2%

5.9%


You may also like the below Video Courses